High-ly Sensitive Information: Use of FDA's DMF Process to Protect Cannabis Trade Secrets

Retrieved on: 2021-06-17 14:26:15

Tags for this article:

Health sciences

Health care

Health

Pharmaceutical industry

Entheogens

Euphoriants

Medicinal plants

Food and Drug Administration

Drug Master File

Investigational New Drug

Cannabis

Clinical research

u.s. food and drug administration

Click the tags to see associated articles and topics

High-ly Sensitive Information: Use of FDA's DMF Process to Protect Cannabis Trade Secrets. View article details on hiswai:

Excerpt

The U.S. Food and Drug Administration (“FDA”) is strongly encouraging cannabis producers to share information regarding their clinical studies with ...

Article found on: www.crowelltradesecretstrends.com

View Original Article